[PharmaEssentia] Announcement of significant resolutions from the 2026 annual general meeting (acting by the Board) of major subsidiary FanTai Medical Products Co., Ltd.

1. Date of annual general meeting: 2026/05/15 2. Important resolution I, distribution of surplus or compensation for losses: Approved the loss recovery plan for 2025. 3. Important resolution II, revision of articles of incorporation: None. 4. Important resolution III, business report and financial statements: Approved the 2025 financial report and business report. 5. Important resolution IV, election of directors and supervisors: None. 6. Important resolution V, other matters: None. 7. Other matters to be stated: None.